Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	248432.81	19543.08	7.86
Graham Fair Price	-89.12	0.30	2.78
PEG	248194.17	0.70	< 0.005
Price/Book	-58.61	0.61	1.48
Price/Cash Flow	-71.83	-3.49	12.40
Prices/Earnings	-3382.38	-69.17	-1.99
Price/Sales	-40.76	49.38	83.36
Price/FCF	-71.83	-3.49	12.40
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.14	1.00	1.00
Operating Margin	98.37	-0.16	-10.05
ROA	98.81	< 0.005	-0.16
ROE	-0.19	< 0.005	98.81
ROIC	-0.18	< 0.005	98.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.11	-0.11	-5.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-35.56	0.99	-97.22
EPS QOQ	-70.44	0.99	-98.60
FCF QOQ	16.47	-2.47	-85.01
Revenue QOQ	-0.29	-0.30	-3.05
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-133979.66	0.00	inf
Days Sales Outstanding (DSO)	21.51	34.76	61.59
Inventory Turnover	< 0.005	0.00	inf
Debt/Capitalization	0.02	0.01	-11.27
Quick Ratio	1.84	0.44	-76.22
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.36	1.35	-0.24
Cash	0.32	0.07	-78.60
Capex	< 0.005	< 0.005	80.58
Free Cash Flow	0.16	-0.24	46.57
Revenue	0.02	0.02	-30.30
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.73	6.78	0.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.09	-105.75	-9560.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating